Common: diarrhoea (the most frequent side effect and can become severe if not managed promptly), nausea and vomiting, loss of appetite, and mild fatigue from a temporary drop in blood cell counts. Less common: mouth sores, skin reactions, and elevated liver enzymes. Serious/rare: severe dehydration from unmanaged diarrhoea, marked bone marrow suppression leading to a higher infection risk, and liver toxicity — any of these need urgent medical attention.

Prescription Compliance: Take/use Uratuf 100mg/224mg Capsule exactly as prescribed by your oncologist; do not self-adjust dose, frequency, or duration. • Drug Interactions: May interact with anticoagulants such as warfarin (increased bleeding risk — INR monitoring advised), antiepileptics such as phenytoin, stomach-acid reducers such as cimetidine, and folate/folic acid supplements. Grapefruit and grapefruit juice may also alter drug levels. Live vaccines should be avoided during treatment because of the immunosuppressive effect. • Medical History: Share your complete medical history, including heart, liver, and kidney conditions, before starting Uratuf 100mg/224mg Capsule. • Pregnancy and Breastfeeding: This medicine should not be used during pregnancy or breastfeeding unless specifically advised by your doctor. • Safe Storage: Store below 25°C. Protect from moisture and sunlight. Keep out of reach of children and pets. Do not use beyond the expiry date.